Jobs / United States / Novartis Pharmaceuticals Corporation
Radioligand Therapies (RLT) Associate Director, Priority Accounts – Kentucky/Tennessee/South Carolina
Novartis Pharmaceuticals Corporation · 🇺🇸 Field Non-Sales (USA)
Sponsorship verdict
Posting rules out sponsorship
The posting rules out sponsorship or requires citizenship/clearance.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting says it won’t sponsorIts own wording says sponsorship is unavailable.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Novartis Pharmaceuticals Corporation paid sponsored hires in similar roles1 certified filing for “Associate Clinical Development Medical Director” (Medical Scientists, Except Epidemiologists) in NJ: $117k–$117k, median $117k. Most were filed at wage level III (100%) — 3 lottery entries, ≈46% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Why not apply?
The posting states sponsorship is unavailable. Applying is unlikely to lead anywhere if you need sponsorship.
SponsorApply flags time-wasters so your applications go where they can land. These come from the posting's own wording — read the original listing to confirm. See better-fit alternatives →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary #LI-Remote This is a field-based and remote opportunity supporting key accounts in an assigned geography. Novartis is unable to offer relocation support for this role. Please only apply if this location is accessible to you. Company will not sponsor visas for this position. As a Radioligand Therapies (RLT) Associate Director, Priority Accounts, you’ll partner with Neuroendocrine Tumors (NET) Centers of Excellence and health care system sites to drive impactful engagement. This role focuses on creating and executing strategic business plans for key accounts while collaborating with cross-functional teams to deliver institution-centric programs aligned with business priorities and compliance standards. You’ll lead commercial strategies, foster strong relationships with senior stakeholders, and provide operational and financial insights to uncover new opportunities. Success in this position calls for expertise in healthcare systems, access navigation, and collaborative problem-solving. Job Description Key Responsibilities: • Champion institutional advocacy for the adoption of the Radioligand Therapies (RLT) and Neuroendocrine Tumors (NET) brand to support appropriate product utilization. • Build strong partnerships with Neuroendocrine Tumors Centers of Excellence and health care system sites to drive impactful engagement. • Develop, coordinate, and execute strategic business plans for priority accounts, ensuring alignment with market dynamics and organizational goals. • Cultivate relationships with clinical, operational, and administrative decision-makers; and support their efforts to streamline care pathways, treatment protocols and workflow solutions to enable patient access. • Stay informed on market trends, customer economics, and access models, including payment programs and reimbursement strategies. • Compliantly share knowledge of Novartis’ offerings and ensure account administrators have access to relevant resources, while maintaining compliance. • Collaborate with local teams to create tailored, institution-specific plans that reflect local market forces and opportunities. • Educate clinicians, staff and other institutional stakeholders on disease state and/or product information as appropriate to support institutional adoption of Radioligand Therapies (RLT) and development of relevant treatment pathways and protocols. • Develop a clear understanding of customer needs across the ecosystem – from departments to executive leadership. Use insights to anticipate trends, shape priorities, and deliver impactful outcomes. • Support team members in diagnosing business challenges and implementing strategies that optimize outcomes for Radioligand Therapies and Neuroendocrine Tumors accounts and affiliated health systems. Essential Requirements: • Bachelor’s degree required from 4-year college or university. • 8+ years’ experience in pharmaceutical, biotech, healthcare, or similarly structured industries with large, geographically dispersed field teams. We also welcome candidates from other complex environments such as medical devices, diagnostics, life sciences services, insurance, consumer health, or B2B sectors, especially where strong field leadership and customer engagement are central to success . • 2+ years’ experience in project management and translation of strategy into execution. • 3+ years’ experience managing complex accounts, including large academic centers and hospitals, with demonstrated success in strategic account management. • Recent US experience (within last 5 years) with deep understanding of US healthcare ecosystems. • Demonstrated deep customer and cross-functional knowledge, healthcare ecosystem thinking, with strong business acumen and technology/digital engage